WORLAND STEPHEN T (President and Chief Executive) received a stock award from EFFECTOR THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 11/16/2023ACC: 0001209191-23-055557
DirectorOfficer· President and Chief Executive
Since Aug 2021
+5.98K
Net shares
Net buyer
$3.0K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
5.98K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+5.98K
Price / share
$0.50
Trade value
$2.97K
% of position
2.3%
11/15/2023
261.23K→267.20K
Total
Net shares
+5.98K
Net value
$2.97K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/15/2023 | A · Award | +5.98K | $0.50 | $2.97K | 2.3% | 261.23K | 267.20K |
| Total | +5.98K | $2.97K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned562.34K
Total
562.34K indirect562.34K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 562.34K | Indirect |
| Total | 562.34K | 562.34K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported